1 completed, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Chemotherapy regimen: new trials by email Literature Review of Chemotherapy regimen trials Research Report on Chemotherapy regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) Photodynamic therapy-Photofrin, Stenting procedure, Chemotherapy regimen - Hilar Cholangiocarcinoma | Phase 3 | Terminated | Concordia Laboratories Inc. | 28 | 2014-11-12 | 2019-08-28 |
| Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel Balugrastim, Pegfilgrastim, Chemotherapy Regimen - Chemotherapy-induced Neutropenia | Phase 2 / Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 334 | 2008-08-21 | 2024-04-03 |
Bile Duct Neoplasms (1) · Cholangiocarcinoma (1) · Klatskin Tumor (1)
Concordia Laboratories Inc. (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
Canada (1) · Germany (1) · South Korea (1) · Switzerland (1) · United States (1)